David Lucchino is the founder of Frequency Therapeutics. Latest round: Series A. Backed by CoBro Ventures, Morningside Ventures, Emigrant Capital Corp..
David Lucchino is a life sciences CEO and entrepreneur with nearly two decades of executive leadership experience. He is the Co-founder, President, and Chief Executive Officer of Frequency Therapeutics, a company pioneering a novel approach to regenerative medicine with programs for hearing loss and multiple sclerosis. Prior to Frequency, Lucchino was CEO of Entrega Bio and co-founded Semprus BioSciences, which was acquired by Teleflex in 2012. He also worked at Polaris Partners and served as Chairman of the Board of Directors of MassBio.
Full founder directory · Investor directory · Company funding database · Fundraising library